SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-790214
Filing Date
2016-12-12
Accepted
2016-12-12 07:01:02
Documents
3
Period of Report
2016-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d308534d8k.htm 8-K 18439
2 EX-99.1 d308534dex991.htm EX-99.1 8174
3 GRAPHIC g308534g27e56.jpg GRAPHIC 11928
  Complete submission text file 0001193125-16-790214.txt   39002
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 162045346
SIC: 2834 Pharmaceutical Preparations